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Abstract: Axonal transport and neuronal survival depend critically on active transport and 
axon integrity both for supplying materials and communication to different domains of the 
cell body. All these actions are executed through cytoskeleton, transport and regulatory 
elements that appear to be disrupted in neurodegenerative diseases. Motor-driven transport 
both supplies and clears distal cellular portions with proteins and organelles. This transport 
is especially relevant in projection and motor neurons, which have long axons to reach the 
farthest  nerve  endings.  Thus,  any  disturbance  of  axonal  transport  may  have  severe 
consequences for neuronal function and survival. A growing body of literature indicates 
the presence of alterations to the motor molecules machinery, not only in expression levels 
and  phosphorylation,  but  also  in  their  subcellular  distribution  within  populations  of 
neurons, which are selectively affected in the course of neurodegenerative diseases. The 
implications of this altered subcellular localization and how this affects axon survival and 
neuronal  death  still  remain  poorly  understood,  although  several  hypotheses  have  been 
suggested. Furthermore, cytoskeleton and transport element localization can be selectively 
disrupted in some disorders suggesting that specific loss of the axonal functionality could 
be a primary hallmark of the disorder. This can lead to axon degeneration and neuronal 
death  either  directly,  through  the  functional  absence  of  essential  axonal  proteins,  or 
indirectly,  through  failures  in  communication  among  different  cellular  domains.  This 
review  compares  the  localization  of  cytoskeleton  and  transport  elements  in  some 
neurodegenerative disorders to ask what aspects may be essential for axon survival and 
neuronal death. 
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1. Introduction 
Axon  degeneration  is  perhaps  the  most  common  and  dangerous  damage  after  brain  injury  for 
several reasons. The white matter constitutes the major portion of the brain volume. All the brain 
anatomical subdivisions are permeated by axons coming or directed to other brain regions. Axons are 
very sensitive to damage. Generally, the majority of brain insults are initially restricted only to a brain 
region. Following the initial damage, the axons passing through or terminating on the damaged region 
begin to degenerate, propagating the damage to other brain regions. This subsequent damage spreading 
is often observed to produce clinical complications, which may represent the disease degenerative 
course and gradually worsen the patient’s quality of life. Further, damage spreading may represent the 
pathogenic  convergence  of  different  types  of  insults  in  the  same  anatomical  area  on  a  common 
neurodegenerative disease mechanism. Finally, damage spreading is a mechanism playing a variable 
role in probably all neurodegenerative conditions. 
2. Axon: The Most Sensitive Neuronal Domain 
Cells are dependent on active transport to perform physiological processes and maintain vitality. 
This is particularly true for neuronal cells, which are endowed by long and specialized processes: 
axons and dendrites. In particular, axons are long and thin structures presenting specialized signaling 
endings that make contact with spines, and require continuous supply and clearance of materials [1,2]. 
The  structural  and  functional  features  of  the  axon  are  determined  and  maintained  by  the  specific 
positioning of its organelles and proteins, which must be tightly regulated. The different classes of 
organelles transported within axons behave differently [3], and the signals that control organelle traffic 
are diverse. As an additional level of complexity, active transport is very often intimately associated 
with protein and organelles processing and maturation. Thus, the functional architecture of neurons 
makes them particularly dependent on intracellular transport processes.  
It is generally believed that about 0.2% of the neuronal volume is in the cytoplasmic soma and 
99.8% is represented by the axon and dendrites [3,4] (Figure 1). Maintaining such enormous cellular 
outgrowth and regulating its traffic are probably the major challenges for the nervous system, which is 
accomplished through the combined support of physiological processes derived from neuronal cell 
bodies  and  axon-associated  glial  cells  [5].  The  majority  of  neural  tissue  volume  appears  to  be 
composed of axons and dendrites, and these are dependent on active transport from cell bodies to 
maintain the vitality. This is reflected in aging and in diseases phenomena. In healthy aging, in humans, 
the major reduction of brain volume is thought to be in the white matter, which contain the axons of 
projection neurons [6]. Analyses of tissue loss in neurologically normal individuals demonstrate that 
atrophy is largely confined to the white matter and accounts for about 50% [6], while the total number 
of cortical neurons in persons ranging from 20 to 90 years varies less than 10% [7].  
The other cellular compartment that is severely affected in aging and during neurodegenerative 
diseases is the dendrite. Loss of spines and consequent dendrite retraction is a common distinguishing 
mark  in  several  neurodegenerative  diseases  [8].  Nonetheless,  in  contrast  to  axonopathy,  a  clear 
―dendritopathy‖ has still not been characterized; and it is generally believed that damage to a dendritic 
domain can remain localized without spreading to the other dendritic branches or without generating a Int. J. Mol. Sci. 2012, 13                       
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retrograde death reaction. The reasons for this resistance can be found in the different dendrite spatial 
arrangement, but it is highly conceivable that differences in protein transport mechanisms make the 
dendrites less susceptible to retrograde death phenomena compared to axons. These two cellular domains, 
axons and dendrites, appear to be the primary sites of damage in aging and after brain injuries.  
Figure  1.  Sketches  of  a  dorsal  root  ganglion  (DRG)  neuron.  (A)  Typical  textbook 
representation of a pseudounipolar DRG neuron; (B) Proportional drawing of the different 
cellular regions giving the perception of the geometrical relations among the cell body and 
the axonal domain. From Devor, M. Unexplained peculiarities of the dorsal root ganglion. 
Pain 1999, Suppl 6, S27–S35. 
 
Aging can be considered a physiological degenerative process while traumatic/vascular injuries can 
occur frequently during a lifetime. Aging and traumatic/vascular injuries are factors which very often 
create  a  general  predisposition  to  degenerative  insults  and  may  represent  the  degenerative  frames 
where  insults  of  different  nature  trigger  pathological  reactions  and  develop  their  own  course. 
Traumatic/vascular injuries are acute forms of  damage that, due to the high percentage of axonal 
volume in the nervous system, and independently from the specific type of injury, invariably provoke 
axonal  damage.  After  axonal  damage,  axons  undergo  Wallerian  degeneration  [9,10]  or  dye  back 
degeneration [9], which ultimately lead to cell bodies atrophy and loss [11]. In the last  years the 
availability of YFP fluorescent mice and in vivo imaging techniques allowed direct observations to be 
made on the early phases after axonal damage. Wallerian degeneration is characterized by focal axon 
swellings forming varicosities, or larger spheroids, within 6 h of axotomy in vivo which extends in a Int. J. Mol. Sci. 2012, 13                       
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rapid, asynchronous and progressive fashion [12]. Varicosities are arranged in a ―beads-on-a-string‖ 
pattern resembling the connected, alternating regions of axonal dilation and constriction which have 
been reported in a wide range of brain diseases [12,13]. For more details on axotomy degeneration 
processes  in  wt  and  (WldS)  mutant  mice,  see  [12,13].  These  varicosities  contain  organelles  and 
cytoskeletal proteins suggesting that 6 h after damage axonal transport is disrupted. However, these 
varicosities did not contain a large accumulation of mitochondria that would have been expected if 
focal dilation of the axon was caused by impaired mitochondrial transport. This could suggest that early 
axonal transport deficits are not directly causing swelling [13]. Of note, one of the earliest events after 
axonal damage is the accumulation of both APP and Abeta proximal to the disrupted segment [14,15]. 
This occurs before or simultaneously to the appearance of morphological evidence of axonal damage, 
and  in  a  wide  range  of  disorders  [14,15].  The  immunoreaction  in  damaged  axons  after  head  
trauma remains positive for up to 1 month and becomes positive 1–3 h after the insult [16], suggesting 
that  the  impairment  of  axonal  transport  and  APP  processing  is  one  of  the  earliest  events  after  
axonal damage [9,17].  
It is difficult to obtain information after the early phase of axonal damage by in vivo observations, 
and can be gathered only by ex vivo indirect examinations. After axotomy, two phases of neuronal  
loss can be described: one confined to the first week and dominated by a high neuronal loss, and a 
second  characterized  by  a  lower  neuronal  loss  and  the  induction  of  reactive  neuronal  and  glial 
phenomena [18–20]. In the second phase, neuronal protein inductions are distributed to the axonal 
domain demonstrating that protein synthesis and axonal transport are active [18]. Although, after two 
or  three  months,  neuronal  loss  is  almost  complete  demonstrating  that  the  reactive  neurons  are 
committed to death [21]. Collectively, observations on axotomy experimental models  suggest that 
axonal  transport  is  disrupted  when  neuronal  loss  is  rapid  and  passes  through  the  disruption  of 
morphological axonal features. However, when neuronal loss is slow, and not accompanied by evident 
morphological alterations  axonal  transport appears to  be preserved, although transport impairment 
cannot be excluded. 
3. Transport Machinery: Roads, Vehicles and Traffic Regulation. 
Active transport is executed through cytoskeleton, transport and regulatory elements and the spatial 
and temporal regulation of motor-based transport is essential to ensure precise cargo delivery. We have 
gained sufficient knowledge on the structural elements that allow active transport, but how transport is 
regulated is less well understood. Regulation of the transport traffic can be executed through different 
mechanisms:  comprising  posttranslational  modifications  and  phosphorylation  of  cytoskeleton  and 
transport  elements.  Besides these  molecular modifications,  which appear to  shape  the transport  in 
axonal subdomains, there are specific families of molecules that act in the selection of cargoes. 
Cytoskeleton structures are composed of polymers of two different classes of molecules: tubulin 
and actin. Tubulin polymers are hollow cylinders about 24 nm in diameter (lumen = approximately  
15 nm in diameter), most commonly comprising 13 protofilaments which, in turn, are polymers of 
alpha and beta tubulin [22,23]. These cytoskeletal filaments are formed from the head-to-tail assembly 
of α- and β-tubulin dimers that serve as tracks for the motors [23]. A characteristic property of these 
polymeric structures is their ability to undergo cycles of rapid growth and disassembly. This is known Int. J. Mol. Sci. 2012, 13                       
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as dynamic instability and individual microtubules do not reach a steady-state length, but exist in either 
polymerization (growth) or depolymerization (shrinkage) states [22]. Tubulin polymers are oriented in 
a polarized array in the axon, with their plus, or fast growing ends, directed toward axonal endings, 
and their minus, or slow growing ends, directed toward the cell body. Therefore, anterograde axonal 
transport is necessarily plus-end directed, whereas retrograde axonal transport is minus-end directed. 
Polymeric  tubulin  organization  is  more  complex  in  dendrites,  where  the  mixed  polarity  seen  in 
mammalian  neurons  may  contribute  to  axonal-dendritic  sorting  and  specification  [22].  Polymeric 
tubulin  presents  two  intrinsic  mechanisms  of  regulation:  the  incorporation  of  alternative  tubulin 
isoforms  and  post-translational  modification  of  the  tubulin  subunits  [24].  The  other  cytoskeletal 
structures are linear polymers of actin subunits. They are the thinnest filaments of the cytoskeleton 
acting as tracks for the movement of myosin molecules that attach to the microfilament and ―walk‖ 
along them [23]. 
Transport elements are responsible for the intracellular transport of a wide variety of components 
and for positioning them along the axon with high spatial-temporal precision. Three different classes 
of motors are involved in this task: dynein and kinesin, which transport cargoes toward the minus and 
plus ends of microtubules, respectively, and myosin, responsible for the transport along actin filaments. 
Kinesins and dyneins, which attach on microtubule roads, are an extended superfamily of proteins [25–
27]. Kinesin tail domains are divergent, which allows coupling to a diverse array of cargos. Many 
kinesins are microtubule-based motors, some are microtubule depolymerizers, while the function of 
others has yet to be explored. Kinesin proteins (KIFs) comprise several major groups depending on the 
position of the motor domain within the molecule  [28]. Kinesins  are known to  drive anterograde 
axonal transport [2] including the three major families kinesin-1 (aka KHC or KIF5), kinesin-2 (aka 
KIF3), and kinesin-3 (aka KIF1). Kinesins functions are mainly regulated through the phosphorylation 
state. Two mechanisms for the phosphorylation dependent regulation of kinesins can be indicated. 
First, kinesin phosphorylation may control the association and dissociation of motors with their cargos. 
Second,  kinesin  phosphorylation  may  modulate  the  binding  of  kinesins  to  microtubules  [25,26]. 
Kinesins often recognize scaffold proteins or adaptor proteins and bind to cargo membrane proteins 
indirectly as part of a protein complex. In other cases, kinesins directly bind to membrane proteins in 
the cargo. Three different mechanisms have been implicated in the regulation of the unloading of 
cargos from kinesins: phosphorylation of kinesins or cargos, control by small G proteins and Ca
2+ 
signaling  [25,28].  Cytoplasmic  dynein  is  the  major  minus  end-directed  microtubule  motor  in  the 
neuron and is involved in retrograde axonal transport [1]. Dynein is a large protein complex with two 
heavy chains that form the two motor domains, as well as associated intermediate, light intermediate, 
and light chains that are involved in cargo recognition and binding specificity. 
Regulatory elements are a growing family of molecules, and the list is rapidly expanding [26]. 
Dynactin is a large, multi-subunit complex required as an activator for most dynein functions in the 
cell, including retrograde axonal transport. The largest subunit of dynactin is p150Glued, which binds 
directly to dynein and the microtubule. Multiple mutations in the DCTN1 gene encoding p150Glued 
cause neurodegeneration. Vesicular cargos are transported along the axon by both kinesin and dynein 
motors. The activity of these cargo-bound motors may be co-regulated by scaffolding proteins such as 
JIPs and Htt/HAP1 that can interact with either kinesin or dynein motors, or potentially with both [26].  Int. J. Mol. Sci. 2012, 13                       
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An important regulatory point is the management of cargo delivery: which implies the recognition 
of both the type of cargo and of the specific delivery location. The need to deliver selected materials to 
specialized  axonal  subdomains  implies  the  existence  of  targeting  and  docking  mechanisms.  For 
example,  neurotransmitter-bearing  synaptic  vesicles  need  to  be  delivered  to  presynaptic  terminals, 
whereas vesicles bearing sodium channels should be selectively delivered to nodes of Ranvier [29]. To 
accomplish  this  work,  neurons  rely  heavily  on  phosphorylation-dependent  intracellular  signaling 
mechanisms, which help in the spatial and temporal coordination and regulation of many cellular 
processes  within  axons,  including  fast  axonal  transport  [2].  Cumulative  data  indicates  that 
phosphorylation  of  molecular  motors  represents  a  major  mechanism  for  regulation  of  fast  axonal 
transport in vivo [30,31]. These regulatory mechanisms provide an explanation for delivery of selected 
motor cargoes to specialized axonal subcompartments. Of particular interest,  the activity of many 
kinases that regulate fast axonal transport are increased in degeneration diseases, as reflected by the 
aberrant patterns of protein phosphorylation [32]. One of the more striking examples is the increase in 
Tau phosporylation in several neurodegenerative pathologies [33]. However, the mechanism by which 
Tau is abnormally phosphorylated and how this is associated with Tau aggregation and intraneuronal 
accumulation are still not clear. Further, retrograde axonal transport can be altered at multiple levels. 
Impairment of transport can arise from direct mutations in microtubule motors or their activators and 
adaptors. Finally, pathological changes along the axon, such as remodeling of the cellular cytoskeleton 
as an injury adaptation mechanism or the development of protein aggregates, could deleteriously affect 
retrograde axonal transport.  
Recently,  some  papers  have  linked  aberrant  protein  phosporylation  with  the  disruption  of 
mitochondrial transport and neuronal death in several neurodegenerative diseases. Mitochondria use 
motors of the kinesin families, along with cytoplasmic dynein, to translocate along microtubules [34]. 
The  decline  in  mitochondrial  functions  plays  a  key  role  in  the  aging  process  and  increases  the 
incidence  of  age-related  disorders  [35].  Mitochondrial  dysfunctions  present  direct  effects  on  ATP 
generation,  calcium  homeostasis,  production  of  reactive  oxygen  species,  and  interaction  with 
cytoskeleton proteins [36]. Moreover, Aβ and tau proteins trigger mitochondrial dysfunction through  
a number of pathways, such as impairment of oxidative phosphorylation, elevation of reactive oxygen 
species  production,  alteration  of  mitochondrial  dynamics  (Figure  2),  and  interaction  with 
mitochondrial proteins [37–39].  Int. J. Mol. Sci. 2012, 13                       
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Figure  2.  NH2-tau  fragment  immunoreactivity  (green  channel)  colocalizes  with  the 
adenine  nucleotide  translocator-1  (ANT-1)  protein  (red  channel)  in  cyoplasmatic 
mitochondria  in  Alzheimer’s  disease  tissue.  Note  the  tau  accumulation  in  fragmented 
mitochondria surrounding the neuronal nuclei (blue channel). Scale bar 10 μm. 
 
4. Cytoskeleton Composition of Axons Is Related to Environmental Stimuli 
Cytoskeleton composition is typical of the specific cellular domains, is primarily related to the fiber 
caliber,  and  appears  to  be  shaped  by  cellular  functions  and  environmental  conditions.  Spines  are 
primarily made of filamentous actin; dendrites and axons are made up of tubulin polymers. However, 
their specific compositions are shaped not only by the different functions in relation to the different 
subcellular domains: but also by the different cellular stimuli eliciting different cellular responses. 
The microtubular density (microtubules/μm
2) of axons is an inverse function of their caliber, and 
independent of the myelin sheath [40,41]. For a given axonal size, the density is the same irrespective 
of the length of the axon, the nerve examined, the age of the animal, the developing or regenerating 
condition of the nerve, the nutritional status, or the species surveyed. Motor and sensory axons span 
from the cord through the root to the peripheral nerve. For axons of equal size, the microtubular 
density in the root is half that of the intracord or peripheral domains. This holds for axons regardless of 
whether they are sensory or motor, myelinated or unmyelinated, spinal or cranial [40–42]. Therefore, 
axoplasmic  proteins  are  arrayed  differently  in  the  root  as  compared  to  intracord  or  peripheral 
trajectories, i.e., the axonal phenotype correlates with the environment, while the neuronal class (motor, 
sensitive, or sympathetic) is irrelevant [43]. To investigate the mechanisms of local regulation of the 
axonal phenotype, axonal central branches were allowed to regenerate along the hypoglossal nerve by 
means of a surgical anastomosis or, as a control, along its anatomical trajectory. When the central 
branches  regenerated  along  their  anatomical  trajectory,  the  original  low  microtubular  density  was 
found,  while  upon  regeneration  along  the  foreign  peripheral  nerve,  a  high  density  was  found. 
Therefore, the phenotype of the axon correlated with the environment, not with the central nature of 
the branch [43]. The microtubules and size of axons also are affected by electrical activity. A high and 
prolonged discharge increases both microtubular content and caliber of axons [41,44]. In conclusion, 
the molecular composition of the axoplasm varies in relation to its history and its environment. Int. J. Mol. Sci. 2012, 13                       
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5. Adult Onset Neurodegenerative Diseases Involve Axonopathy and Transport Deficit  
Adult  onset neurodegenerative diseases  are a heterogeneous  group of diseases  presenting some 
unifying themes. They are progressive and their clinical phenotype results from an age-dependent 
decline in selected neuronal populations that is initially associated with loss of synaptic activity and 
axonopathy and later with neuronal death [2]. They present a common histological picture which is 
characterized by three main aspects: lesions related to accumulation of proteic products, lesions related 
to  neuronal  losses,  and  reactive  processes  such  as  inflammation  and  plasticity  [45].  For  most 
neurodegenerative  conditions,  injury  may  originate  either  from  unknown  stressors  in  the  case  of 
sporadic disease, or from expression of a mutant gene in the familial forms. Familial and sporadic 
forms often present nearly indistinguishable clinical course, suggesting pathogenic convergence on 
common disease mechanisms [2,46]. In addition, all of the genes whose mutation causes the inherited 
forms of these diseases are widely or ubiquitously expressed in several tissues or in all neurons [2], 
although their mutation induces degeneration only in a selected neuronal population. The accumulation 
of organelles and proteins in the cell body and axon are suggestive of axonopathies for many human 
neurodegenerative diseases. Aggregates of mutant Huntingtin protein (htt) are detected in Huntington’s 
disease (HD), accumulation of tau and β-amyloid proteins is detected in Alzheimer’s disease (AD),  
α-synuclein  positive  Lewy  bodies  are  observed  in  Parkinson’s  disease  (PD)  and  neurofilament 
accumulations are seen in amyotrophic lateral sclerosis (ALS). These pathologies suggest that impaired 
axonal transport may underlie the pathogenic accumulations of proteins in neurodegenerative diseases [47]. 
Clinical  deficits  in  neurodegenerative  disorders  are  associated  with  the  location,  rather  than 
mechanism, of brain cell death. The regional selectivity and variability of neuronal loss in different 
neurodegenerative disorders is reflected in the variety of different and overlapping clinical dementia 
and movement disorder syndromes characterized by neurodegeneration. While the type and location of 
cells degenerating in each disorder varies widely, it appears that the range of mechanisms by which the 
cells die are less broad, with many disorders sharing a small number of neurodegenerative mechanisms 
in  common.  Among  these  the  most  ubiquitous  are  protein  aggregation,  oxidative  stress, 
neuroinflammation and apoptosis [48].  
Axonal and cell body accumulation of proteins and organelles are hallmark pathologies for many 
human neurodegenerative diseases. Tau and β-amyloid are present in several and different types of 
tissue lesions in Alzheimer’s and related diseases. α-Synuclein is the principal component of Lewy 
bodies  in  Parkinson’s  disease.  Neurofilament  accumulation  is  seen  in  ALS,  and  more  recently,  
TDP-43  accumulation  has  been  observed  in  ALS  and  frontotemporal  lobar  degeneration  [49–51]. 
Furthermore, axonal swellings and spheroids have been described in a number of neurodegenerative 
diseases [9]. Together, such pathologies suggest that defective functioning of the axon contributes to 
disease and, in particular, that damage to axonal transport may underlie the pathogenic accumulation 
of organelles. Early axonal and synaptic degeneration in neurodegenerative diseases are consistent 
with active transport alterations. Evidence indicating that alterations in active transport suffice to produce 
selective neuronal degeneration comes from genetic studies. Specifically, mutations in genes coding 
for microtubule-based molecular motor subunits can result in ―dying back‖ neuropathologies [32,52]. 
Often  the  length  of  axons  is  assumed  to  correlate  with  increased  vulnerability  to  active  transport 
defects.  Although  it  is  conceivable  that  vulnerability  arises  from  the  length,  size  and  nature  of Int. J. Mol. Sci. 2012, 13                       
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anatomical connections, mutations affecting different subunits of the same motor protein may induce 
dramatically  different  pathologies,  suggesting  additional  levels  of  molecular  and  cellular  
complexity  [53,54].  Of  note,  most  adult  onset  neurodegenerative  diseases  are  not  associated  with 
mutations in molecular motors, or other proteins, so other mechanisms must be responsible for changes 
in altered transport [2].  
6. Conclusions 
Neurodegenerative diseases display complex and selective brain topographical distribution of the 
cellular  damage,  due  to  damage  spreading  following  axonal  degeneration.  The  axon  is  the  most 
sensitive cellular domain and this sensitivity relates to the peculiar spatial arrangement and the high 
dependence  of  intracellular  transport  processes.  Transport  processes  are  compromised  under 
neurodegenerative conditions and their restoration may provide therapeutic tools. 
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